Yvet Noordman

Yvet Noordman

Company: Sanofi

Job title: Head of Analytical Development, Bioanalytics Genomic Medicine


Methods to Characterise NK Cells for Best-in-Class Cellular Therapeutics 4:00 pm

Sanofi off-the-shelf NK-cell platform is based on NK-cells from a unique universal donor, expanded and activated ex vivo using the PM21 particle technology Outlining approaches on characterisation of expanded NK cells Addressing how to overcome challenges with measuring low levels of cellular impuritiesRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.